Please sign in to follow a disease.
Alcohol gel vs steroid: which injection eases disc pain longer?
NCT ID NCT03415828
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two types of injections for people with long-term low back pain caused by one or two damaged discs. One injection uses an ethanol gel (DISCOGEL), the other uses a steroid. Both are already approved and used in practice. The goal is to see which provides better pain relief over time, with 230 participants followed for two years.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- ethanol gel (DISCOGEL) and prednisolone acetate (steroid)
- What this could lead to
- If DISCOGEL works better than steroids, it could offer a longer-lasting, non-surgical option for people with chronic disc-related back pain.
- What could go wrong
- This is a post-market study confirming existing use, not a breakthrough. The ethanol gel is already on the market, so results may not show a major advantage over steroids. Pain relief varies and some people may not respond.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 230 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2018
- Expected to finish
-
May 2027
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patient 18 years of age or older; * 2-month refractory pain to conservative treatment, non-surgical patients; * Chronic discogenic pain (1 or 2 lumbar discs) with concordant MR imaging; * Symptomatic for at least 8 weeks despite appropriate medical treatment; * Patient who agrees to participate in the study and who signed the informed consent form; * Patient with social protection. Exclusion Criteria: * Previous surgical treatment of the studied disc(s); * Patient with pure radicular pain; * Sick leave of more than 12 months secondary to the symptoms; * Patients who cannot read or write French; * History of cognitive-behavioral disorders that could interact with assessment by self-questionnaire; * Local or general infection, or suspicion of infection; * Severe coagulation disorders; * Other rheumatic inflammatory disease; * Undercurrent serious pathology with life expectancy \< 2 years; * Female of childbearing age that are known to be pregnant during inclusion visit or wishing to become pregnant before treatment; * Subject who has forfeited their freedom by administrative or legal award, or is under guardianship or under limited judicial protection * Patient participating in another interventional clinical trial or testing an experimental drug within 30 days of inclusion in the study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Lumbar discogenic pain (disorder) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
3 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Hospital Pellegrin
RECRUITINGBordeaux, France
-
Hospital SUD La Reunion
RECRUITINGSaint-Pierre, France
-
Hospital St-Dié-des-Vosges
TERMINATEDSaint-Dié, France
-
Hospital St-Etienne
RECRUITINGSaint-Priest-en-Jarez, France
-
Hospital Valence
TERMINATEDValence, France